Stephen Maxted Ansell, MD, PhD

  • 23253 Citations
  • 81 Scopus h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 + T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma

Yang, Z. Z., Kim, H. J., Villasboas, J. C., Price-Troska, T., Jalali, S., Wu, H., Luchtel, R. A., Polley, M. Y. C., Novak, A. J. & Ansell, S. M., Feb 19 2019, In : Cell reports. 26, 8, p. 2178-2193.e3

Research output: Contribution to journalArticle

Open Access
12 Scopus citations

Nivolumab for newly diagnosed advanced-stage classic Hodgkin lymphoma: Safety and efficacy in the phase II CheckMate 205 study

Ramchandren, R., Domingo-Domènech, E., Rueda, A., Trněný, M., Feldman, T. A., Lee, H. J., Provencio, M., Sillaber, C., Cohen, J. B., Savage, K. J., Willenbacher, W., Ligon, A. H., Ouyang, J., Redd, R., Rodig, S. J., Shipp, M. A., Sacchi, M., Sumbul, A., Armand, P. & Ansell, S. M., Aug 10 2019, In : Journal of Clinical Oncology. 37, 23, p. 1997-2007 11 p.

Research output: Contribution to journalArticle

35 Scopus citations

Nivolumab for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for or having failed autologous transplantation: A single-arm, phase II study

Ansell, S. M., Minnema, M. C., Johnson, P., Timmerman, J. M., Armand, P., Shipp, M. A., Rodig, S. J., Ligon, A. H., Roemer, M. G. M., Reddy, N., Cohen, J. B., Assouline, S., Poon, M., Sharma, M., Kato, K., Samakoglu, S., Sumbul, A. & Grigg, A., 2019, In : Journal of Clinical Oncology. 37, 6, p. 481-489 9 p.

Research output: Contribution to journalArticle

45 Scopus citations

Progression risk stratification of asymptomatic Waldenström macroglobulinemia

Bustoros, M., Sklavenitis-Pistofidis, R., Kapoor, P., Liu, C. J., Kastritis, E., Zanwar, S., Fell, G., Abeykoon, J. P., Hornburg, K., Neuse, C. J., Marinac, C. R., Liu, D., Soiffer, J., Gavriatopoulou, M., Boehner, C., Cappuccio, J. M., Dumke, H., Reyes, K., Soiffer, R. J., Kyle, R. A. & 6 others, Treon, S. P., Castillo, J. J., Dimopoulos, M. A., Ansell, S. M., Trippa, L. & Ghobrial, I. M., 2019, In : Journal of Clinical Oncology. 37, 16, p. 1403-1411 9 p.

Research output: Contribution to journalArticle

13 Scopus citations

Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma

Luchtel, R. A., Zimmermann, M. T., Hu, G., Dasari, S., Jiang, M., Oishi, N., Jacobs, H. K., Zeng, Y., Hundal, T., Rech, K. L., Ketterling, R. P., Lee, J. H., Eckloff, B. W., Yan, H., Gaonkar, K. S., Tian, S., Ye, Z., Kadin, M. E., Sidhu, J., Jiang, L. & 11 others, Voss, J., Link, B. K., Syrbu, S. I., Facchetti, F., Bennani, N. N., Slager, S. L., Ordog, T., Kocher, J. P., Cerhan, J. R., Ansell, S. M. & Feldman, A. L., Jun 27 2019, In : Blood. 133, 26, p. 2776-2789 14 p.

Research output: Contribution to journalArticle

5 Scopus citations

Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

Jalali, S., Price-Troska, T., Bothun, C., Villasboas Bisneto, J. J. C. ., Kim, H. J., Yang, Z. Z., Novak, A. J., Dong, H. M. & Ansell, S. M., Mar 1 2019, In : Blood cancer journal. 9, 3, 22.

Research output: Contribution to journalArticle

7 Scopus citations

SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma

Chen, Y. P., Kim, H. J., Wu, H., Price-Troska, T., Villasboas, J. C., Jalali, S., Feldman, A. L., Novak, A. J., Yang, Z. Z. & Ansell, S. M., Oct 1 2019, In : Blood cancer journal. 9, 10, 84.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Wu, X., Stenson, M., Abeykoon, J., Nowakowski, K., Zhang, L., Lawson, J., Wellik, L., Li, Y., Krull, J., Wenzl, K., Novak, A. J., Ansell, S. M., Bishop, G. A., Billadeau, D. D., Peng, K. W., Giles, F., Schmitt, D. M. & Witzig, T. E., Jul 25 2019, In : Blood. 134, 4, p. 363-373 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

The highs and lows of immune-checkpoint blockade in lymphoma

Ansell, S. M., May 1 2019, In : Cancer Immunology Research. 7, 5, p. 696-700 5 p.

Research output: Contribution to journalArticle

3 Scopus citations

Two types of amyloidosis presenting in a single patient: a case series

Sidiqi, M. H., McPhail, E., Theis, J. D., Dasari, S., Vrana, J. A., Drosou, M. E., Leung, N., Hayman, S., Rajkumar, S. V., Warsame, R., Ansell, S. M., Gertz, M., Grogan, M. & Dispenzieri, A., Mar 1 2019, In : Blood cancer journal. 9, 3, 30.

Research output: Contribution to journalArticle

6 Scopus citations
2020

A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

Armand, P., Lesokhin, A., Borrello, I., Timmerman, J., Gutierrez, M., Zhu, L., Popa McKiver, M. & Ansell, S. M., 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Open Access

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

Straus, D. J., Długosz-Danecka, M., Alekseev, S., Illés, Á., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Ramchandren, R., Zinzani, P. L., Hutchings, M., Connors, J. M., Radford, J., Munoz, J., Kim, W. S., Advani, R., Ansell, S. M. & 6 others, Younes, A., Miao, H., Liu, R., Fenton, K., Forero-Torres, A. & Gallamini, A., Mar 5 2020, In : Blood. 135, 10, p. 735-742 8 p.

Research output: Contribution to journalArticle

3 Scopus citations

Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management

Ansell, S. M., Aug 1 2020, In : American journal of hematology. 95, 8, p. 978-989 12 p.

Research output: Contribution to journalArticle

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

Sidana, S., Larson, D. P., Greipp, P. T., He, R., McPhail, E. D., Dispenzieri, A., Murray, D. L., Dasari, S., Ansell, S. M., Muchtar, E., Gonsalves, W. I., Kourelis, T. V., Ramirez-Alvarado, M., Kapoor, P., Rajkumar, S. V., Lacy, M. Q., Buadi, F. K., Leung, N., Kyle, R. A., Kumar, S. K. & 2 others, King, R. L. & Gertz, M. A., May 1 2020, In : Leukemia. 34, 5, p. 1373-1382 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Immunomodulators in Lymphoma

Anagnostou, T. & Ansell, S. M., Apr 1 2020, In : Current treatment options in oncology. 21, 4, 28.

Research output: Contribution to journalArticle

Immunotherapy of lymphomas

Ansell, S. M. & Lin, Y., Apr 1 2020, In : Journal of Clinical Investigation. 130, 4, p. 1576-1585 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

Zanwar, S., Abeykoon, J. P., Durot, E., King, R., Perez Burbano, G. E., Kumar, S., Gertz, M. A., Quinquenel, A., Delmer, A., Gonsalves, W., Cornillet-Lefebvre, P., He, R., Warsame, R., Buadi, F. K., Novak, A. J., Greipp, P. T., Inwards, D., Habermann, T. M., Micallef, I., Go, R. & 19 others, Muchtar, E., Kourelis, T., Dispenzieri, A., Lacy, M. Q., Dingli, D., Nowakowski, G., Thompson, C. A., Johnston, P., Thanarajasingam, G., Bennani, N. N., Witzig, T. E., Villasboas, J., Leung, N., Lin, Y., Kyle, R. A., Rajkumar, S. V., Ansell, S. M., Le-Rademacher, J. G. & Kapoor, P., Mar 1 2020, In : American journal of hematology. 95, 3, p. 274-281 8 p.

Research output: Contribution to journalArticle

3 Scopus citations

NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020

Mehta-Shah, N., Horwitz, S. M., Ansell, S., Ai, W. Z., Barnes, J., Barta, S. K., Clemens, M. W., Dogan, A., Fisher, K., Goodman, A. M., Goyal, G., Guitart, J., Halwani, A., Haverkos, B. M., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Lunning, M. A., Mehta, A., Olsen, E. A. & 14 others, Pro, B., Rajguru, S. A., Shanbhag, S., Shaver, A., Shustov, A., Sokol, L., Torka, P., Torres-Cabala, C., Wilcox, R., William, B. M., Zain, J., Dwyer, M. A., Sundar, H. & Kim, Y. H., May 1 2020, In : Journal of the National Comprehensive Cancer Network : JNCCN. 18, 5, p. 522-536 15 p.

Research output: Contribution to journalArticle

Open Access

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 28 2020, In : Leukemia and Lymphoma. 61, 2, p. 318-327 10 p.

Research output: Contribution to journalArticle

1 Scopus citations

Role of Microenvironment in Non-Hodgkin Lymphoma: Understanding the Composition and Biology

Khurana, A. & Ansell, S. M., May 1 2020, In : Cancer journal (Sudbury, Mass.). 26, 3, p. 206-216 11 p.

Research output: Contribution to journalArticle

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

Ansell, S. M., Flinn, I., Taylor, M. H., Sikic, B. I., Brody, J., Nemunaitis, J., Feldman, A., Hawthorne, T. R., Rawls, T., Keler, T. & Yellin, M. J., May 12 2020, In : Blood Advances. 4, 9, p. 1917-1926 10 p.

Research output: Contribution to journalArticle

Open Access

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

Hartert, K. T., Wenzl, K., Krull, J. E., Manske, M., Sarangi, V., Asmann, Y., Larson, M. C., Maurer, M. J., Slager, S., Macon, W. R., King, R. L., Feldman, A. L., Gandhi, A. K., Link, B. K., Habermann, T. M., Yang, Z. Z., Ansell, S. M., Cerhan, J. R., Witzig, T. E., Nowakowski, G. S. & 1 others, Novak, A. J., 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

The immune landscape and response to immune checkpoint blockade therapy in lymphoma

Kline, J., Godfrey, J. & Ansell, S. M., Feb 20 2020, In : Blood. 135, 8, p. 523-533 11 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations